中华检验医学杂志2024,Vol.47Issue(2) :197-204.DOI:10.3760/cma.j.cn114452-20230729-00032

游离DNA检测技术及其在疾病诊疗中的应用和研究进展

Application and research progress of cell-free DNA in the diagnosis and treatment of related disease

陆昕怡 孟庆泰 黄萍 段雅干 陈智远 徐鹏 张凤民 武昱
中华检验医学杂志2024,Vol.47Issue(2) :197-204.DOI:10.3760/cma.j.cn114452-20230729-00032

游离DNA检测技术及其在疾病诊疗中的应用和研究进展

Application and research progress of cell-free DNA in the diagnosis and treatment of related disease

陆昕怡 1孟庆泰 1黄萍 1段雅干 1陈智远 1徐鹏 1张凤民 1武昱
扫码查看

作者信息

  • 1. 哈尔滨医科大学医学微生物学教研室,伍连德研究所,黑龙江省免疫与感染重点实验室,黑龙江省普通高校病原生物学重点实验室,哈尔滨 150081
  • 折叠

摘要

游离DNA(cfDNA)是存在于人体细胞外液中的DNA片段,在生理或病理条件下(如妊娠、肿瘤等),cfDNA的含量变化和分子特征等使其成为疾病诊疗的生物标志物之一。随着cfDNA富集技术以及测序、质谱等检测技术的发展,cfDNA的检测已形成完整的检验流程。基于cfDNA检测的液体活检技术在临床肿瘤诊疗、产前检查中已得到广泛应用,并且在自身免疫病诊疗中展现出较大的潜力。本综述描述了cfDNA检测技术的发展和液体活检在临床方面的应用,以及cfDNA在疾病诊断和治疗中的研究进展。 Cell-free DNA (cfDNA) is the DNA fragment existing in human extracellular fluid. In specific physiological process (such as pregnancy) or pathological conditions (such as human malignancies), the contents of cfDNA in extracellular fluid will abnormally change. The contents and molecular characteristics of cfDNA make it have the potential as a kind of biomarker for diseases′ diagnosis. With the development of cfDNA detection technology such as sequencing and mass spectrometry, liquid biopsy based on cfDNA detection has been widely used in clinical tumor diagnosis, tumor treatment, prenatal examination, and research in autoimmune diseases. A systematic summary of the latest research progress in the development of cfDNA detection technology and the clinical application of liquid biopsy, as well as the research progress of cfDNA in the diagnosis and treatment of related diseases is summarized in this review.

Abstract

Cell-free DNA (cfDNA) is the DNA fragment existing in human extracellular fluid. In specific physiological process (such as pregnancy) or pathological conditions (such as human malignancies), the contents of cfDNA in extracellular fluid will abnormally change. The contents and molecular characteristics of cfDNA make it have the potential as a kind of biomarker for diseases′ diagnosis. With the development of cfDNA detection technology such as sequencing and mass spectrometry, liquid biopsy based on cfDNA detection has been widely used in clinical tumor diagnosis, tumor treatment, prenatal examination, and research in autoimmune diseases. A systematic summary of the latest research progress in the development of cfDNA detection technology and the clinical application of liquid biopsy, as well as the research progress of cfDNA in the diagnosis and treatment of related diseases is summarized in this review.

关键词

基因检测/测序/癌症/产前检查/自身免疫病

Key words

Gene test/Sequencing/Cancer/Prenatal examination/Autoimmune disease

引用本文复制引用

基金项目

国家重点研发计划(2017YFB0403805)

出版年

2024
中华检验医学杂志
中华医学会

中华检验医学杂志

CSTPCDCSCD北大核心
影响因子:1.402
ISSN:1009-9158
参考文献量85
段落导航相关论文